Back to Search
MR. JOSHUA C. BRAMSON MD
MD
Hematology & Oncology Physician
NPI: 1902937105IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Rehabilitation Practitioner
Rehabilitation Practitioner
Code: 225400000X
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
25MA11113200(NJ)
Education
OTHER
Class of 2015
Research & Publications (20)
Super-activated interferon-regulatory factors can enhance plasmid immunization.
PMID 12615431·Vaccine·2003
7-preclinical
The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen.
PMID 11772342·Expert Opin Biol Ther·2002
6-review
Activation of host antitumoral responses by cationic lipid/DNA complexes.
PMID 10766341·Cancer Gene Ther·2000
4-observational
Deciphering epitope specificities within polyserum using affinity selection of random peptides and a novel algorithm based on pattern recognition theory.
PMID 19038455·Mol Immunol·2009
8-other
CD4+ T-cell-mediated anti-tumor immunity can be uncoupled from autoimmunity via the STAT4/STAT6 signaling axis.
PMID 19338001·Eur J Immunol·2009
7-preclinical
Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus.
PMID 19603003·Mol Ther·2009
7-preclinical
Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties.
PMID 19654411·Blood·2009
7-preclinical
Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity.
PMID 19401673·Mol Ther·2009
7-preclinical
High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome.
PMID 18989352·Cancer Gene Ther·2009
7-preclinical
Characterizing complex polysera produced by antigen-specific immunization through the use of affinity-selected mimotopes.
PMID 19390580·PLoS One·2009
7-preclinical
Neoadjuvant vaccination provides superior protection against tumor relapse following surgery compared with adjuvant vaccination.
PMID 19383917·Cancer Res·2009
7-preclinical
Tumor protection following vaccination with low doses of lentivirally transduced DCs expressing the self-antigen erbB2.
PMID 18180774·Mol Ther·2008
7-preclinical
The memory T cell response to West Nile virus in symptomatic humans following natural infection is not influenced by age and is dominated by a restricted set of CD8+ T cell epitopes.
PMID 18606712·J Immunol·2008
8-other
Enhanced antitumor immunity elicited by dendritic cell vaccines is a result of their ability to engage both CTL and IFN gamma-producing NK cells.
PMID 18059374·Mol Ther·2008
7-preclinical
A novel computer algorithm improves antibody epitope prediction using affinity-selected mimotopes: a case study using monoclonal antibodies against the West Nile virus E protein.
PMID 18760481·Mol Immunol·2008
8-other
Obstacles to effective Toll-like receptor agonist therapy for hematologic malignancies.
PMID 18176602·Oncogene·2008
6-review
Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes.
PMID 18299564·Proc Natl Acad Sci U S A·2008
4-observational
Elevated frequencies of self-reactive CD8+ T cells following immunization with a xenoantigen are due to the presence of a heteroclitic CD4+ T-cell helper epitope.
PMID 17616707·Cancer Res·2007
7-preclinical
Induction of epitope-specific neutralizing antibodies against West Nile virus.
PMID 17715236·J Virol·2007
7-preclinical
Critical negative regulation of type 1 T cell immunity and immunopathology by signaling adaptor DAP12 during intracellular infection.
PMID 17785840·J Immunol·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 425 Jack Martin Blvd
Brick, NJ 08724 - Phone
- (732) 897-3682
Quick Facts
- NPI
- 1902937105
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile